189 related articles for article (PubMed ID: 23276939)
21. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.
Aeschlimann D; Thomazy V
Connect Tissue Res; 2000; 41(1):1-27. PubMed ID: 10826705
[TBL] [Abstract][Full Text] [Related]
22. Transglutaminase-2, RNA-binding proteins and mitochondrial proteins selectively traffic to MDCK cell-derived microvesicles following H-Ras-induced epithelial-mesenchymal transition.
Shafiq A; Suwakulsiri W; Rai A; Chen M; Greening DW; Zhu HJ; Xu R; Simpson RJ
Proteomics; 2021 Jul; 21(13-14):e2000221. PubMed ID: 33638284
[TBL] [Abstract][Full Text] [Related]
23. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
[TBL] [Abstract][Full Text] [Related]
24. GTP-binding-defective forms of tissue transglutaminase trigger cell death.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2007 Dec; 46(51):14819-29. PubMed ID: 18052077
[TBL] [Abstract][Full Text] [Related]
25. Targeted inactivation of Gh/tissue transglutaminase II.
Nanda N; Iismaa SE; Owens WA; Husain A; Mackay F; Graham RM
J Biol Chem; 2001 Jun; 276(23):20673-8. PubMed ID: 11274171
[TBL] [Abstract][Full Text] [Related]
26. Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
Park KS; Kim HK; Lee JH; Choi YB; Park SY; Yang SH; Kim SY; Hong KM
J Cancer Res Clin Oncol; 2010 Apr; 136(4):493-502. PubMed ID: 19763620
[TBL] [Abstract][Full Text] [Related]
27. Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
Agnihotri N; Kumar S; Mehta K
Breast Cancer Res; 2013 Feb; 15(1):202. PubMed ID: 23673317
[TBL] [Abstract][Full Text] [Related]
28. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase.
Monsonego A; Friedmann I; Shani Y; Eisenstein M; Schwartz M
J Mol Biol; 1998 Oct; 282(4):713-20. PubMed ID: 9743620
[TBL] [Abstract][Full Text] [Related]
29. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
[TBL] [Abstract][Full Text] [Related]
30. Efficient Production of a Thermostable Mutant of Transglutaminase by
Ye J; Yang P; Zhou J; Du G; Liu S
J Agric Food Chem; 2024 Feb; 72(8):4207-4216. PubMed ID: 38354706
[TBL] [Abstract][Full Text] [Related]
31. Tissue transglutaminase during mouse central nervous system development: lack of alternative RNA processing and implications for its role(s) in murine models of neurotrauma and neurodegeneration.
Citron BA; Zoloty JE; Suo Z; Festoff BW
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):122-33. PubMed ID: 15857675
[TBL] [Abstract][Full Text] [Related]
32. GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.
Iismaa SE; Wu MJ; Nanda N; Church WB; Graham RM
J Biol Chem; 2000 Jun; 275(24):18259-65. PubMed ID: 10747935
[TBL] [Abstract][Full Text] [Related]
33. Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
Kang S; Oh SC; Min BW; Lee DH
Anticancer Res; 2018 Feb; 38(2):787-794. PubMed ID: 29374703
[TBL] [Abstract][Full Text] [Related]
34. Tissue transglutaminase: a possible role in neurodegenerative diseases.
Lesort M; Tucholski J; Miller ML; Johnson GV
Prog Neurobiol; 2000 Aug; 61(5):439-63. PubMed ID: 10748319
[TBL] [Abstract][Full Text] [Related]
35. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis.
Tatsukawa H; Hitomi K
Cells; 2021 Jul; 10(7):. PubMed ID: 34360011
[TBL] [Abstract][Full Text] [Related]
36. Inter-molecular crosslinking activity is engendered by the dimeric form of transglutaminase 2.
Kim N; Lee WK; Lee SH; Jin KS; Kim KH; Lee Y; Song M; Kim SY
Amino Acids; 2017 Mar; 49(3):461-471. PubMed ID: 27394142
[TBL] [Abstract][Full Text] [Related]
37. Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
Cho SY; Oh Y; Jeong EM; Park S; Lee D; Wang X; Zeng Q; Qin H; Hu F; Gong H; Liu X; Zhang G; Na D; Lee J; Chae J; Suh YS; Kong SH; Lee HJ; Kim JI; Park H; Zhang C; Yang HK; Lee C
Exp Mol Med; 2020 May; 52(5):854-864. PubMed ID: 32467608
[TBL] [Abstract][Full Text] [Related]
38. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
39. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord.
Festoff BW; SantaCruz K; Arnold PM; Sebastian CT; Davies PJ; Citron BA
J Neurochem; 2002 May; 81(4):708-18. PubMed ID: 12065630
[TBL] [Abstract][Full Text] [Related]
40. Lack of genetic association of the TGM2 gene with schizophrenia in a Chinese population.
Wang J; Liu Y; Wang Z; Du W; Hui L; Zhao X; Zhao X; Zhang X; Wei J
Psychiatr Genet; 2015 Dec; 25(6):259-62. PubMed ID: 26307914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
